https://www.drugtargetreview.com/the-data-fragmentation-problem-holding-drug-discovery-back/681456.article 2026-04-01T14:42:59.297Z https://www.drugtargetreview.com/agentic-ai-teaching-machines-to-think-like-scientists/681800.article 2026-04-01T14:42:38.717Z https://www.drugtargetreview.com/why-tau-still-lacks-treatments-and-how-funders-are-responding/681835.article 2026-04-02T11:35:59.370Z https://www.drugtargetreview.com/ai-steps-into-drug-safety-predicting-liver-injury-earlier-than-ever-before/681842.article 2026-04-01T14:41:26.500Z https://www.drugtargetreview.com/how-aggressive-breast-cancer-evades-the-immune-system/681955.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/fertility-beyond-ivf-therapeutic-advances-in-reproductive-biotech/681959.article 2026-04-02T13:26:23.617Z https://www.drugtargetreview.com/polysaccharide-microneedles-the-future-of-cancer-immunotherapy/681976.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/controlling-cellular-noise-may-stop-cancer-and-bacterial-relapse/681989.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/insilico-secures-888million-servier-partnership-for-ai-oncology/682003.article 2026-03-12T14:21:35.840Z https://www.drugtargetreview.com/trpm5-protein-switch-discovery-could-lead-to-new-diabetes-drugs/682015.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/propofol-and-insulin-may-reduce-cognitive-decline-in-older-age/682046.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/pitavastatin-identified-as-potential-treatment-for-triple-negative-breast-cancer/682057.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/new-lumos-ai-platform-targets-precision-in-mental-health-drugs/682071.article 2026-04-01T08:46:14.123Z https://www.drugtargetreview.com/new-ai-genomics-platform-targets-kidney-and-cardiorenal-disease/682077.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/new-study-links-prenatal-dna-screening-to-better-cmv-treatment-decisions/682106.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/new-type-2-diabetes-drugs-may-improve-insulin-sensitivity/682118.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/quality-over-quantity-drug-discovery-automation-in-2026/682127.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/maternal-stress-may-alter-foetal-brain-development-via-immune-pathways/682164.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/otulin-enzyme-found-to-drive-tau-and-brain-ageing/682184.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/schrödinger-partners-with-lilly-tunelab-on-ai-drug-discovery/682202.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/magnetic-stimulation-advances-heart-organoids-for-future-therapies/682218.article 2026-03-13T12:12:48.507Z https://www.drugtargetreview.com/2026-the-year-ai-stops-being-optional-in-drug-discovery/682243.article 2026-04-01T14:37:18.747Z https://www.drugtargetreview.com/rare-sugars-point-to-future-therapies-for-alcohol-dependence/682252.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-study-revives-long-doubted-target-for-depression-drugs/682266.article 2026-03-13T12:15:13.630Z https://www.drugtargetreview.com/insitro-expands-ai-drug-discovery-with-combinableai-acquisition/682272.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/targeting-inflammatory-cell-death-to-tackle-relapse-in-aml/682273.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/disrupting-the-biologics-market-through-innovations-in-macrocycle-randd/682282.article 2026-04-01T15:06:47.080Z https://www.drugtargetreview.com/functional-retinal-organoids-improve-drug-testing-for-eye-disease/682306.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-fluorescent-technology-tracks-drug-responses-in-cells/682330.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/new-techno-platform-enables-large-scale-human-gene-integration-in-mice/682351.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/rethinking-drug-discovery-through-transcription-factor-biology/682367.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/claudin-182-targeted-therapy-advances-gi-cancer-treatment/682390.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/reports/crispr-and-genomics-turning-data-into-confident-drug-discovery-decisions/682398.article 2026-04-17T14:11:51.513Z https://www.drugtargetreview.com/beige-fat-identified-as-potential-target-for-blood-pressure-drugs/682410.article 2026-04-01T08:46:03.750Z https://www.drugtargetreview.com/scientists-develop-synthetic-bacteriophages-to-fight-drug-resistant-bacteria/682439.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/virus-mimicking-lenn-nanoparticles-deliver-mrna-to-bladder-cancer-cells/682447.article 2026-03-13T12:13:36.773Z https://www.drugtargetreview.com/drug-development-in-2026-nams-safety-and-regulatory-changes/682457.article 2026-04-14T08:26:05.943Z https://www.drugtargetreview.com/new-alco5-platform-could-advance-cancer-antibody-therapies/682475.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/how-ageing-cells-affect-brain-development-and-neurodegeneration/682484.article 2026-04-01T08:46:40.630Z https://www.drugtargetreview.com/hiv-drug-maraviroc-could-be-used-to-slow-glioblastoma-growth/682508.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-generative-ai-method-could-make-drug-discovery-faster/682515.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/elrig-announces-keynote-speakers-for-cell-and-gene-therapy-2026-in-cambridge/682551.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/new-dual-cdk-approach-tackles-drug-resistant-breast-cancer/682563.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/targeting-cpla2-enzyme-may-reduce-brain-inflammation-in-alzheimers/682595.article 2026-03-19T10:30:30.913Z https://www.drugtargetreview.com/centrifuge-technique-creates-functional-bioengineered-lymph-nodes/682602.article 2026-04-01T08:46:32.440Z https://www.drugtargetreview.com/beyond-serendipity-rational-design-and-ais-expansion-of-the-undruggable-target-landscape/682619.article 2026-04-15T13:24:51.040Z https://www.drugtargetreview.com/brain-discovery-could-improve-drugs-targeting-amyloid-diseases/682633.article 2026-04-01T08:45:53.740Z https://www.drugtargetreview.com/mini-stomach-organoids-grown-to-improve-disease-research/682655.article 2026-03-13T12:09:53.643Z https://www.drugtargetreview.com/cc023-mice-reveal-how-als-can-develop-after-viral-infections/682684.article 2026-03-19T10:26:10.560Z https://www.drugtargetreview.com/premium-members-qualification/853560.article 2026-03-12T12:24:02.483Z https://www.drugtargetreview.com/ai-in-drug-discovery-predictions-for-2026/1865962.article 2026-04-15T13:31:43.050Z https://www.drugtargetreview.com/vibe-coding-101-for-drug-discovery-scientists/1866024.article 2026-03-24T22:52:37.830Z https://www.drugtargetreview.com/ai-begins-to-enter-alzheimers-drug-discovery-pipelines/1866033.article 2026-03-31T09:04:16.277Z https://www.drugtargetreview.com/new-paper-warns-against-phasing-out-animal-testing-too-quickly/1866062.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/hdac11-protein-identified-as-potential-target-for-duchenne-muscular-dystrophy/1866080.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/tangible-scientific-launches-platform-to-streamline-compound-logistics/1866101.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-shank3-conditional-knockout-mouse-model-launched-for-pms-research/1866118.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/drug-target-reviews-women-in-stem/1866127.article 2026-03-24T22:52:37.837Z https://www.drugtargetreview.com/engineering-the-next-generation-of-t-cell-engagers/1866142.article 2026-04-02T13:22:04.700Z https://www.drugtargetreview.com/promega-launches-live-cell-platform-to-expand-the-druggable-proteome/1866159.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/launaea-herb-could-provide-new-treatments-for-peptic-ulcers/1866172.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/how-vaccine-structure-shapes-immune-response-to-hpv-tumours/1866184.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/why-ageing-must-become-central-to-parkinsons-research/1866206.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/siglec-15-identified-as-key-target-in-paediatric-brain-cancer/1866217.article 2026-03-24T22:52:37.840Z https://www.drugtargetreview.com/new-serpinb2-immune-cell-discovery-could-reverse-type-2-diabetes/1866226.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/memory-linked-brain-cells-offer-new-obesity-target-for-future-therapies/1866257.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-oc-pam-ai-tool-tracks-cancer-organoid-drug-response/1866276.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-organoid-model-helps-test-spinal-cord-regeneration-drugs/1866286.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/the-map-and-compass-integrating-bdandl-early-to-de-risk-drug-discovery/1866300.article 2026-04-15T13:08:18.330Z https://www.drugtargetreview.com/replacing-animals-in-science-what-the-uks-new-strategy-means/1866311.article 2026-04-02T13:21:00.373Z https://www.drugtargetreview.com/why-pde4b-matters-in-the-search-for-better-ipf-and-ppf-therapies/1866320.article 2026-04-01T07:56:08.217Z https://www.drugtargetreview.com/advancing-drug-discovery-with-reproducible-animal-free-3d-systems/1866337.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/amd3100-drug-could-boost-immunotherapy-in-rare-liver-cancer/1866343.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/insilico-and-msk-partner-on-ai-research-for-gastroesophageal-cancer/1866366.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/32m-project-targets-aggressive-mdm2-in-breast-cancer/1866390.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/targeting-senescent-cells-may-reduce-postpartum-breast-cancer-risk/1866399.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/lario-raises-24m-for-neurological-drug-development/1866429.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/making-immunotherapy-safer-and-more-accessible-through-continuous-digital-monitoring/1866437.article 2026-04-02T13:11:48.650Z https://www.drugtargetreview.com/new-method-boosts-production-of-non-natural-amino-acids-for-peptide-assembly/1866449.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/cat-cancer-study-reveals-targets-for-human-drugs/1866464.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/camel-derived-peptides-target-multidrug-bacteria/1866493.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/messy-lipid-nanoparticles-deliver-rna-more-effectively/1866505.article 2026-03-24T22:52:37.857Z https://www.drugtargetreview.com/how-tuberculosis-bacteria-outsmart-human-immune-cells/1866519.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/bispecific-egfr/epha2-targeting-adc-shows-promise-in-colorectal-cancer/1866550.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/circular-rna-drives-50-fold-boost-in-eye-gene-therapy/1866565.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/integrated-proteo-transcriptomics-reveals-multiple-therapeutic-targets-in-candida-auris/1866577.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/how-self-driving-labs-are-changing-drug-development/1866601.article 2026-04-01T07:44:54.970Z https://www.drugtargetreview.com/ark1-identified-as-target-for-future-malaria-drugs/1866611.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-precision-glp-1-agonist-could-reduce-side-effects-in-patients/1866625.article 2026-03-30T09:50:47.653Z https://www.drugtargetreview.com/pex38-protein-identified-as-drug-target-for-trypanosome-parasites/1866673.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-molecular-pathway-links-liver-congestion-to-fibrosis/1866682.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/water-interaction-key-to-smarter-nanomedicine-design/1866701.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/drug-discovery-integration-takes-centre-stage-at-slas-boston-2026/1866703.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/preclinical-takeaways-from-the-world-adc-conference-london/1866716.article 2026-04-01T09:04:37.320Z https://www.drugtargetreview.com/blocking-growth-hormone-may-improve-resistant-lung-cancer-treatment/1866742.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/why-most-labs-are-not-ready-for-ai-cenevo-shares-what-must-change/1866754.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/stem-cells-from-baby-teeth-could-treat-cerebral-palsy/1866779.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/elrig-appoints-dr-kelly-gray-and-dr-elaine-duncan-to-board/1866795.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/how-brain-donation-is-driving-autism-research/1866805.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/flare-therapeutics-streamlines-drug-discovery-with-simplicis-ledger/1866830.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/new-ai-foundation-model-aims-to-speed-up-drug-discovery/1866838.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/international-womens-day-digital-pathology-in-early-drug-discovery/1866856.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/psychedelics-may-repair-brain-myelin-to-aid-ptsd-recovery/1866865.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/gut-drug-boosts-liver-health-in-mice-after-small-bowel-surgery/1866875.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/blocking-fak-protein-may-help-to-overcome-resistance-in-ovarian-cancer/1866896.article 2026-03-24T22:52:37.867Z https://www.drugtargetreview.com/navigating-ind-delays-strategic-options-for-early-phase-biotech-development/1866900.article 2026-04-02T12:59:22.850Z https://www.drugtargetreview.com/new-ai-tool-could-accelerate-drug-discovery-and-cut-lab-costs/1866960.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/designing-targeted-assays-for-clinical-success-from-the-start/1866966.article 2026-04-02T13:07:56.730Z https://www.drugtargetreview.com/discovery-is-changing-and-automation-leads-the-way/1866978.article 2026-04-01T09:09:33.803Z https://www.drugtargetreview.com/world-adc-2026-where-antibody-drug-conjugates-are-heading/1866982.article 2026-04-01T09:05:08.430Z https://www.drugtargetreview.com/from-scientist-to-bioinformatician-how-ai-coding-tools-dissolved-the-activation-energy-barrier/1867007.article 2026-04-01T07:47:05.650Z https://www.drugtargetreview.com/new-target-found-for-glaucoma-treatment/1867018.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/why-nmda-receptor-modulation-remains-central-to-next-generation-depression-therapies/1867027.article 2026-04-02T13:19:23.593Z https://www.drugtargetreview.com/lab-made-lncrna-could-lead-to-new-anti-inflammatory-drugs/1867055.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/deep-sea-compound-yakuamide-b-shows-new-cancer-fighting-mechanism/1867064.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/simple-amino-acid-mix-dramatically-improves-gene-therapy-delivery/1867080.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/scientists-develop-cream-that-triggers-skins-anti-cancer-defence/1867097.article 2026-03-24T22:52:37.877Z https://www.drugtargetreview.com/light-driven-chemistry-offers-faster-greener-drug-design/1867106.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/anticipating-adaptation-understanding-and-overcoming-cancer-drug-resistance/1867108.article 2026-04-02T13:01:25.007Z https://www.drugtargetreview.com/computational-design-drives-new-generation-of-synthetic-promoters/1867129.article 2026-04-02T10:04:02.600Z https://www.drugtargetreview.com/new-drug-delivery-system-boosts-paclitaxel-cancer-treatment/1867147.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/physics-based-modelling-offers-a-new-way-to-study-drug-targets/1867156.article 2026-04-02T08:35:15.743Z https://www.drugtargetreview.com/new-rna-injection-could-help-hearts-heal-after-heart-attacks/1867159.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/elrig-announces-keynote-speakers-for-advances-in-cell-based-screening-2026-in-gothenburg/1867191.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/sonopin-ultrasound-method-shows-promise-for-targeted-cancer-therapy/1867208.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/probiotic-bacteria-successfully-attacks-tumours-in-preclinical-models/1867238.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/technology/from-fragments-to-maps-scaling-drug-target-interaction-data/1867250.article 2026-04-02T14:27:01.670Z https://www.drugtargetreview.com/new-ai-designed-t-cell-engager-lgtx-101-to-be-presented-at-aacr-in-san-diego/1867251.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/kma-and-lma-antigens-emerge-as-high-value-targets-for-plasma-cell-dyscrasia-treatment/1867261.article 2026-04-02T13:18:41.180Z https://www.drugtargetreview.com/home/operational-data-the-hidden-driver-of-faster-drug-discovery/1867272.article 2026-04-07T08:27:32.227Z https://www.drugtargetreview.com/pri-101-could-become-first-disease-modifying-parkinsons-drug/2134979.article 2026-03-24T09:31:50.963Z https://www.drugtargetreview.com/gut-microbes-found-to-drive-chronic-kidney-disease/2134983.article 2026-03-24T15:21:30.280Z https://www.drugtargetreview.com/biomarker-discovery-may-improve-schizophrenia-treatment/2134984.article 2026-03-24T15:31:13.653Z https://www.drugtargetreview.com/blocking-protein-pathway-may-slow-huntingtons-disease/2134985.article 2026-03-24T15:43:33.270Z https://www.drugtargetreview.com/toxoplasma-cell-cycle-mapped-for-next-generation-therapies/2134988.article 2026-03-24T15:52:49.767Z https://www.drugtargetreview.com/cd47-protein-found-to-drive-glioblastoma-growth/2134999.article 2026-05-14T11:13:20.797Z https://www.drugtargetreview.com/ai-discovers-peptide-that-eases-ulcerative-colitis-symptoms/2135000.article 2026-03-26T09:03:28.480Z https://www.drugtargetreview.com/new-evidence-links-autoantibodies-to-long-covid/2135001.article 2026-03-26T09:31:42.523Z https://www.drugtargetreview.com/scientists-link-ivns1abp-gene-to-new-ageing-disorder/2135002.article 2026-03-26T09:43:05.090Z https://www.drugtargetreview.com/copd-drug-roflumilast-may-help-fight-breast-cancer-lung-metastasis/2135006.article 2026-04-01T07:22:09.650Z https://www.drugtargetreview.com/haem-signalling-pathway-identified-as-key-driver-of-t-cell-exhaustion/2135014.article 2026-04-01T07:21:25.290Z https://www.drugtargetreview.com/139m-ucla-study-maps-autism-and-schizophrenia-biology-for-drug-discovery/2135028.article 2026-03-28T16:35:00.420Z https://www.drugtargetreview.com/ai/ai-builds-dual-action-cancer-drug-targeting-pkmyt1/2135035.article 2026-04-15T08:33:19.480Z https://www.drugtargetreview.com/implantable-living-pharmacy-device-produces-multiple-drugs-inside-the-body/2135040.article 2026-03-30T09:54:56.370Z https://www.drugtargetreview.com/scientists-scale-up-neural-organoid-studies-for-drug-testing/2135044.article 2026-03-30T15:14:02.750Z https://www.drugtargetreview.com/mirrored-molecules-target-disordered-proteins-in-alzheimers-disease/2135055.article 2026-03-31T09:36:03.487Z https://www.drugtargetreview.com/advertising-tech-specs/drug-target-review-media-and-content-planner-2026/2135062.article 2026-04-16T13:58:14.730Z https://www.drugtargetreview.com/human-antimicrobial-peptide-dermcidin-shows-antiviral-activity-against-influenza/2135069.article 2026-04-01T09:04:05.423Z https://www.drugtargetreview.com/improving-selectivity-in-antibody-drug-conjugates/2135080.article 2026-04-21T00:10:24.500Z https://www.drugtargetreview.com/dna-based-system-delivers-targeted-cancer-drugs-via-biomarker-logic/2135093.article 2026-04-01T13:57:55.053Z https://www.drugtargetreview.com/small-molecule-sk-129-targets-protein-aggregation-in-parkinsons-disease/2135100.article 2026-04-02T09:59:03.650Z https://www.drugtargetreview.com/fgf21-hormone-targets-hindbrain-pathways-to-reverse-obesity/2135106.article 2026-04-02T10:27:01.937Z https://www.drugtargetreview.com/home/ai-to-antibody-in-days-breaking-the-wet-lab-bottleneck-via-high-throughput-integration/2135114.article 2026-04-08T13:05:41.830Z https://www.drugtargetreview.com/dna-needle-bypasses-cellular-defences-to-deliver-therapeutics/2135118.article 2026-04-02T14:19:54.077Z https://www.drugtargetreview.com/lipid-nanoparticles-deliver-dual-therapy-for-lung-cancer/2135130.article 2026-04-07T08:02:02.540Z https://www.drugtargetreview.com/3d-printed-drug-carriers-deliver-chemotherapy-directly-to-tumours/2135131.article 2026-04-07T10:01:39.703Z https://www.drugtargetreview.com/new-osteoarthritis-therapy-targeting-joint-repair-advances-following-preclinical-success/2135146.article 2026-04-08T09:25:29.997Z https://www.drugtargetreview.com/lactylation-emerges-as-key-driver-of-lung-cancer-resistance/2135148.article 2026-04-08T10:51:02.640Z https://www.drugtargetreview.com/molecular-map-reveals-thromboxane-receptor-structure-for-new-blood-clotting-drug-development/2135150.article 2026-04-08T15:13:53.323Z https://www.drugtargetreview.com/zebrafish-drug-screening-identifies-precision-therapies-for-autism/2135156.article 2026-04-09T09:07:40.720Z https://www.drugtargetreview.com/home/analytica-2026-connecting-data-across-drug-discovery-workflows/2135157.article 2026-05-06T11:11:02.533Z https://www.drugtargetreview.com/massey-cancer-center-funds-drug-discovery-projects-targeting-hsp27-cers1-and-ferroptosis-pathways/2135159.article 2026-04-09T10:13:36.193Z https://www.drugtargetreview.com/insilico-announces-ism6200-ai-designed-drug-candidate-for-ovarian-cancer-and-cortisol-disorders/2135163.article 2026-04-09T12:56:13.370Z https://www.drugtargetreview.com/combining-antibodies-with-natural-compounds-may-improve-alzheimers-treatment/2135198.article 2026-04-13T10:14:53.613Z https://www.drugtargetreview.com/champions-oncology-to-present-eight-studies-at-aacr-2026/2135200.article 2026-04-13T11:40:58.907Z https://www.drugtargetreview.com/osteoporosis-drugs-may-slow-progression-of-aortic-aneurysms/2135209.article 2026-04-14T09:50:06.397Z https://www.drugtargetreview.com/ontario-invests-31m-in-next-generation-cancer-therapeutics/2135210.article 2026-04-14T12:46:10.667Z https://www.drugtargetreview.com/elrig-launches-inaugural-us-drug-discovery-conference-2026-in-cambridge-ma/2135216.article 2026-04-15T09:52:35.753Z https://www.drugtargetreview.com/ai-platform-models-protein-flexibility-to-accelerate-drug-design/2135217.article 2026-04-15T10:38:56.617Z https://www.drugtargetreview.com/circio-and-acuitas-partner-on-circular-rna-car-t-therapy/2135220.article 2026-04-15T14:46:35.100Z https://www.drugtargetreview.com/10x-genomics-launches-atera-whole-transcriptome-spatial-biology-platform/2135226.article 2026-04-16T08:35:54.413Z https://www.drugtargetreview.com/nasal-spray-reverses-age-related-brain-inflammation-in-preclinical-study/2135228.article 2026-05-06T07:44:38.217Z https://www.drugtargetreview.com/new-platform-reveals-shared-drug-targets-across-genetic-mutations-in-cancer-and-neurodegeneration/2135229.article 2026-04-16T09:51:23.440Z https://www.drugtargetreview.com/eli-lilly-acquires-crossbridge-bios-dual-payload-adc-platform/2135231.article 2026-04-16T13:25:59.453Z https://www.drugtargetreview.com/ovarian-follicles-provide-new-platform-for-angiogenesis-research/2135232.article 2026-04-16T13:59:31.167Z https://www.drugtargetreview.com/cells-use-nanoparticle-couriers-to-exchange-biological-information/2135233.article 2026-04-16T14:58:33.263Z https://www.drugtargetreview.com/reports/organoids-and-organ-chips-improving-decision-making-in-early-drug-discovery/2135241.article 2026-05-14T10:15:09.417Z https://www.drugtargetreview.com/home/the-future-of-academic-core-labs-scaling-operational-excellence-without-increasing-staff/2135244.article 2026-04-23T10:18:00.010Z https://www.drugtargetreview.com/news/new-strategy-targets-antibiotic-resistance-in-cystic-fibrosis/2135256.article 2026-04-21T14:51:21.270Z https://www.drugtargetreview.com/home/variant-or-viable-target-how-resolving-complex-genomic-regions-is-reshaping-rare-disease-therapeutics/2135260.article 2026-04-23T09:10:46.300Z https://www.drugtargetreview.com/home/why-lower-organisms-matter-for-neurodegeneration-drug-discovery/2135282.article 2026-04-27T08:30:17.490Z https://www.drugtargetreview.com/home/from-leaderboards-to-lab-notebooks-ai-designs-reach-preclinical-testing/2135283.article 2026-05-01T08:11:51.640Z https://www.drugtargetreview.com/home/the-scale-divide-competing-strategies-in-ai-drug-discovery/2135285.article 2026-05-14T10:21:46.270Z https://www.drugtargetreview.com/news/new-method-streamlines-c-n-bond-formation-for-amine-synthesis/2135286.article 2026-04-24T08:19:07.267Z https://www.drugtargetreview.com/new-immune-mapping-reveals-lung-tumour-microenvironment-dynamics/2135295.article 2026-04-27T09:37:17.390Z https://www.drugtargetreview.com/ai-system-detects-pain-in-laboratory-mice-through-facial-analysis/2135297.article 2026-04-27T11:27:06.660Z https://www.drugtargetreview.com/home/from-constraint-to-catalyst-innovation-in-rare-disease-clinical-development/2135310.article 2026-05-12T10:40:05.123Z https://www.drugtargetreview.com/new-approach-targets-undruggable-proteins-in-prostate-cancer/2135313.article 2026-04-28T08:27:46.143Z https://www.drugtargetreview.com/repurposed-cancer-drugs-target-root-cause-of-crohns-disease/2135316.article 2026-04-28T10:14:55.927Z https://www.drugtargetreview.com/home/when-scale-meets-insight-reinventing-spr-for-the-future-of-drug-discovery/2135329.article 2026-05-14T10:18:58.413Z https://www.drugtargetreview.com/new-imaging-reveals-how-immune-cells-destroy-cancer/2135332.article 2026-04-29T12:48:59Z https://www.drugtargetreview.com/aax-biotech-and-evitria-partner-on-antibody-development/2135338.article 2026-04-29T11:43:37.303Z https://www.drugtargetreview.com/hybrid-molecule-shows-enhanced-metabolic-effects-in-obesity-study/2135346.article 2026-04-30T08:39:42.370Z https://www.drugtargetreview.com/home/drug-target-review-launches-new-website-designed-for-drug-discovery-professionals/2135349.article 2026-05-15T13:54:50.190Z https://www.drugtargetreview.com/ai-tool-reveals-dna-exists-in-partially-open-states/2135350.article 2026-04-30T11:26:52.577Z https://www.drugtargetreview.com/new-dual-action-drug-candidate-extends-survival-in-pancreatic-cancer-models/2135360.article 2026-04-30T14:32:07.810Z https://www.drugtargetreview.com/new-see-cite-technology-maps-drug-protein-interactions-with-targeted-precision/2135361.article 2026-05-01T10:41:57.030Z https://www.drugtargetreview.com/safer-diazo-compound-synthesis-advances-medicinal-chemistry-capabilities/2135368.article 2026-05-05T09:56:25.090Z https://www.drugtargetreview.com/machine-learning-identifies-five-distinct-parkinsons-disease-subtypes/2135373.article 2026-05-05T08:03:53.663Z https://www.drugtargetreview.com/metal-microrobots-deliver-drugs-and-biopsies-before-dissolving/2135375.article 2026-05-08T07:50:58.050Z https://www.drugtargetreview.com/bispecific-antibody-targets-wnt-co-receptors-for-diabetic-macular-oedema-treatment/2135380.article 2026-05-06T08:44:17.683Z https://www.drugtargetreview.com/novel-enzyme-inhibitors-exploits-key-weakness-in-malaria-parasite/2135381.article 2026-05-11T11:24:24.093Z https://www.drugtargetreview.com/new-framework-evaluates-ai-reliability-in-immune-system-prediction/2135385.article 2026-05-11T13:06:02.237Z https://www.drugtargetreview.com/openbind-launches-ai-model-to-accelerate-drug-discovery/2135387.article 2026-05-11T13:06:26.800Z https://www.drugtargetreview.com/protein-modifications-control-drug-binding-and-efficacy-in-new-study/2135389.article 2026-05-11T11:15:37.743Z https://www.drugtargetreview.com/yap1-protein-found-to-drive-chemotherapy-resistance-in-small-cell-lung-cancer-after-treatment/2135390.article 2026-05-06T15:41:00.760Z https://www.drugtargetreview.com/home/turning-crispr-hits-into-confident-drug-discovery-decisions/2135405.article 2026-05-14T10:21:21.360Z https://www.drugtargetreview.com/asgct-2026-annual-meeting-opens-in-boston-this-week/2135418.article 2026-05-12T08:37:57.950Z https://www.drugtargetreview.com/two-antimicrobials-show-efficacy-against-drug-resistant-pneumonia-pathogen/2135426.article 2026-05-11T12:59:59.900Z https://www.drugtargetreview.com/molecular-switch-discovery-could-lead-to-new-bone-disease-treatments/2135429.article 2026-05-12T09:55:05.923Z https://www.drugtargetreview.com/home/one-sample-one-shot-the-pressure-on-sample-preparation-in-drug-discovery/2135430.article 2026-05-14T10:19:29.190Z https://www.drugtargetreview.com/ai-system-reduces-animal-testing-in-drug-discovery-by-50-percent/2135437.article 2026-05-12T13:43:05.067Z https://www.drugtargetreview.com/new-malaria-drug-t111-targets-all-parasite-stages-in-single-treatment/2135439.article 2026-05-13T09:37:26.070Z https://www.drugtargetreview.com/ai-system-transforms-weak-antibiotics-into-powerful-treatments/2135440.article 2026-05-13T12:06:28.653Z https://www.drugtargetreview.com/cd4-t-cells-identified-as-key-to-hepatitis-b-clearance/2135453.article 2026-05-14T08:56:32.330Z https://www.drugtargetreview.com/car-t-cell-therapy-eliminates-glioblastoma-tumours-in-preclinical-study/2135461.article 2026-05-14T13:43:13.500Z https://www.drugtargetreview.com/new-rna-sequencing-method-reveals-molecular-structures-at-single-molecule-resolution/2135466.article 2026-05-15T09:35:09.297Z https://www.drugtargetreview.com/mitochondrial-fission-activation-offers-new-route-against-antibiotic-resistance/2135472.article 2026-05-15T14:03:44.567Z https://www.drugtargetreview.com/logged-in-expired-subscriber-fallback/10.article 2026-03-12T12:24:02.483Z https://www.drugtargetreview.com/logged-in-not-a-subscriber-fallback/11.article 2026-03-12T12:24:02.483Z https://www.drugtargetreview.com/not-logged-in-fallback/12.article 2026-03-12T12:24:02.483Z https://www.drugtargetreview.com/logged-out-register-for-accessfallback/853530.article 2026-03-12T12:24:02.483Z https://www.drugtargetreview.com/logged-in-premium-content-no-access/853535.article 2026-03-12T12:24:02.483Z https://www.drugtargetreview.com/lead-generation-eme-access-message/853538.article 2026-03-18T10:04:14.683Z https://www.drugtargetreview.com/what-it-takes-to-automate-high-content-imaging-at-scale/682315.article 2026-05-12T14:37:28.347Z https://www.drugtargetreview.com/16th-world-adc-london/682592.article 2026-03-12T12:24:02.483Z https://www.drugtargetreview.com/ai-in-drug-discovery-2026-conference/1866095.article 2026-03-29T18:53:27.433Z https://www.drugtargetreview.com/aaps-summer-scientific-forum/1867223.article 2026-03-24T22:52:37.887Z https://www.drugtargetreview.com/webinars/manufacturing-the-future-from-n1-personalized-crispr-therapy-to-scalable-precision-genomic-medicine/2135078.article 2026-05-12T14:38:08.977Z https://www.drugtargetreview.com/webinars/from-expert-task-to-lab-routine-membrane-protein-purification-and-analysis-simplified/2135110.article 2026-05-12T14:39:09.330Z https://www.drugtargetreview.com/webinars/where-nams-stand-in-early-drug-discovery-an-expert-discussion/2135134.article 2026-05-12T14:38:40.937Z